Antibiotice SA

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2022, 2021

In its 2023 reporting, Antibiotice SA disclosed greenhouse gas emissions of 13.3K tCO2e/year (market-based). By scope: Scope 1: 9.5K tCO2e/year; Scope 2: 3.8K tCO2e/year (market-based). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
13.3K tCO2e/year (market-based)
2023
⚡
Renewable Energy
60.72%
of total energy
⚙️
Energy Use
219.8K GJ/year
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).9.5K tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.3.8K tCO2e/year (market-based)

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
202313.3K tCO2e/year (market-based)
20229.9K tCO2e (market-based)
202111.2K tCO2e/year (Scope 1 and 2)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

📅 Medium-term

  • €250 million turnover by 2030
  • 6.5% physical market share in Romania by 2030
  • €80 million in international sales by 2030
  • 90% production capacity utilization by 2030
  • €50 million profit by 2030

🌱 ESG Focus Areas

EnvironmentalSocialGovernance

⚠️ Challenges & Risks +

  • High inflation
  • Tight labor market
  • Climate crisis
  • Numerous armed conflicts worldwide
  • Supply chain disruptions due to geopolitical factors and the lingering effects of the pandemic

📋 Report Information

Reporting Period: 2023
Frameworks: GRI 2021 Standards